Despite the fact that at the early stages 5-year survival rate in patients with prostate cancer reaches 100%, not all tumors demonstrate sufficient response to the conventional therapeutic regimens. Therefore, international medical scientists are in the ongoing search for new options. Molecule PSMA-617 that was created by specialists of the University Hospital Heidelberg and German […]
The post Targeted therapy with Lutetium PSMA in Germany: how to know that you are an eligible patient? appeared first on Get Holistic Health.